Mahadevia Ankit — SEC Form 4 filings

SEC reporting owner CIK 1720974. 6 Form 4 filings on record with FilingPulse; latest filed 2025-09-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-05 to 2025-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Spero Therapeutics, Inc. (SPRO)Director65 legs · 145,498 sh · $162,3182

Form 4 filings — Mahadevia Ankit

FiledFormIssuerReported transactionsSource
2025-09-034Spero Therapeutics, Inc. (SPRO)Sale (S): 6,572 @ $1.97EDGAR
2025-06-164Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2025-02-054Spero Therapeutics, Inc. (SPRO)Sale (S): 13,959 @ $0.78 · Sale (S): 55,260 @ $0.78EDGAR
2024-08-294Spero Therapeutics, Inc. (SPRO)Sale (S): 5,912 @ $1.35EDGAR
2024-05-304Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2024-02-054Spero Therapeutics, Inc. (SPRO)Sale (S): 63,795 @ $1.37EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1720974 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →